Bioventus (BVS) Receivables - Net (2020 - 2025)
Bioventus (BVS) has disclosed Receivables - Net for 6 consecutive years, with $131.2 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Receivables - Net rose 2.99% year-over-year to $131.2 million, compared with a TTM value of $131.2 million through Dec 2025, up 2.99%, and an annual FY2025 reading of $131.2 million, up 2.99% over the prior year.
- Receivables - Net was $131.2 million for Q4 2025 at Bioventus, up from $130.4 million in the prior quarter.
- Across five years, Receivables - Net topped out at $148.3 million in Q3 2022 and bottomed at $89.5 million in Q2 2021.
- Average Receivables - Net over 5 years is $123.9 million, with a median of $125.1 million recorded in 2024.
- The sharpest move saw Receivables - Net surged 45.4% in 2021, then fell 19.33% in 2023.
- Year by year, Receivables - Net stood at $128.4 million in 2021, then increased by 6.18% to $136.3 million in 2022, then dropped by 9.91% to $122.8 million in 2023, then grew by 3.75% to $127.4 million in 2024, then grew by 2.99% to $131.2 million in 2025.
- Business Quant data shows Receivables - Net for BVS at $131.2 million in Q4 2025, $130.4 million in Q3 2025, and $135.3 million in Q2 2025.